Patients were immobilized in the prone position using a thermoplastic shell in combination with a vacuum pillow and a leg support. All of the planning protocols used 5–7 field beam arrangements and 6–15 MV photon beams, delivered by the Clinac 2100C or Clinac 2300C/D unit (Varian Medical Systems, Crawley, UK). A clinical target volume (CTV) was created based on the prostate and seminal vesicles, which were contoured by referring to magnetic resonance imaging data. Regarding the setup error reduction strategy, errors were evaluated based on the patient’s pelvic bony structure using film-based portal imaging. The margins for the planning target volume (PTV) were added to the CTV, according to the following 3D settings: 9-mm margins applied universally, except for a 6-mm margin on the rectum side and a 10-mm margin in the caudal direction. Patients in the very high-risk group were treated using the simultaneous integrated boost method, which simultaneously delivers a high-dose (78 Gy) to the prostate and seminal vesicles and a relatively lower-dose (58.5 Gy) to the regional pelvic nodes. Treatment plans were created using the Eclipse Helios system (ver. 6.3–8.2, Varian Associates, Palo Alto, CA, USA). The isodose distributions and dose–volume histograms (DVH) were evaluated according to the clinical criteria described in previous reports [11].
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.